Angela Santonja

发表

Male breast cancer: correlation between immunohistochemical subtyping and PAM50 intrinsic subtypes, and the subsequent clinical outcomes

J. M. Jerez, E. Alba, C. Ramírez-Tortosa, 2018, Modern Pathology.

Luminal androgen receptor role and pathological complete response rate to neoadjuvant chemotherapy in triple negative breast cancer

J. M. Jerez, J. Albanell, A. Prat, 2016 .

Role of germline variants in the metastasis of breast carcinomas

A. González-Neira, A. Lluch, E. Alba, 2022, Oncotarget.

The seed and soil hypothesis revisited: current state of knowledge of inherited genes on prognosis in breast cancer.

E. Alba, N. Ribelles, B. Pajares, 2014, Cancer treatment reviews.

Comparison of tumor‐informed and tumor‐naïve sequencing assays for ctDNA detection in breast cancer

N. Rosenfeld, C. Caldas, O. Rueda, 2023, EMBO molecular medicine.

ctDNA monitoring using patient-specific sequencing and integration of variant reads

N. Rosenfeld, C. Caldas, J. Abraham, 2020, Science Translational Medicine.

Triple negative breast cancer subtypes and pathologic complete response rate to neoadjuvant chemotherapy

Eva Carrasco, Emilio Alba, Ana Lluch, 2018, Oncotarget.

Proliferation Determined by Ki-67 Defines Different Pathologic Response to Neoadjuvant Trastuzumab-Based Chemotherapy in HER2-Positive Breast Cancer.

E. Alba, N. Ribelles, Víctor Navarro-Pérez, 2015, Clinical breast cancer.